Case number 1:23-cv-00732
Biogen Inc. et al v. Zydus Worldwide DMCC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 4, 2024 | 36 | ORAL ORDER: The Court, having reviewed the parties' May 17, 2024 Letter requesting that all remaining claim construction deadlines set forth in the Scheduling Order be canceled (D.I. 34), hereby GRANTS the parties' request. Accordingly, the Markman hearing scheduled for October 2, 2024, at 1:00 pm, is CANCELLED, and all remaining claim construction deadlines are removed from the Court's calendar. ORDERED by Judge Gregory B. Williams on 6/4/2024. (lnb) (Entered: 06/04/2024) (0) |
| May 20, 2024 | 35 | NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-8); and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-47) filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH.(Tigan, Jeremy) (Entered: 05/20/2024) (3) |
| May 17, 2024 | 34 | Joint Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Claim Construction - re 24 Scheduling Order,,. (Tigan, Jeremy) (Entered: 05/17/2024) (1) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney David B. Abramowitz for Zydus Lifesciences Limited,Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 05/14/2024) (0) |
| May 13, 2024 | 33 | NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-46); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories to Zydus (Nos. 1-8). filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 05/13/2024) (2) |
| May 10, 2024 | N/A | SO ORDERED, re 31 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 5/10/2024. (lnb) (Entered: 05/10/2024) (0) |
| May 9, 2024 | 32 | Pro Hac Vice Fee - Credit Card Payment received for David B. Abramowitz. ( re 31 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz )( Payment of $ 50, receipt number ADEDC-4403933).(Stombaugh, Alexis) (Entered: 05/09/2024) (0) |
| May 9, 2024 | 31 | MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Stombaugh, Alexis) (Entered: 05/09/2024) (4) |
| May 9, 2024 | 30 | NOTICE OF SERVICE of Zydus' Initial Invalidity Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 05/09/2024) (2) |
| Apr 12, 2024 | 29 | NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-8); and 2) Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-47). filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 04/12/2024) (2) |
| Apr 12, 2024 | N/A | Pro Hac Vice Attorney Jeremy Murphy for Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | N/A | SO ORDERED, re 27 MOTION for Pro Hac Vice Appearance of Attorney Jeremy E. Murphy filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 4/12/24. (ntl) (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | 28 | Pro Hac Vice Fee - Credit Card Payment received for Jeremy E. Murphy. ( re 27 MOTION for Pro Hac Vice Appearance of Attorney Jeremy E. Murphy )( Payment of $ 50, receipt number ADEDC-4383006).(Stombaugh, Alexis) (Entered: 04/12/2024) (0) |
| Apr 12, 2024 | 27 | MOTION for Pro Hac Vice Appearance of Attorney Jeremy E. Murphy - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Stombaugh, Alexis) (Entered: 04/12/2024) (4) |
| Apr 10, 2024 | 26 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions for Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH.(Tigan, Jeremy) (Entered: 04/10/2024) (3) |
| Apr 4, 2024 | 25 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production of Documents and Things to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited and (2) Plaintiffs' First Set of Interrogatories to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited - filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH.(Tigan, Jeremy) (Entered: 04/04/2024) (3) |
| Mar 15, 2024 | 24 | SCHEDULING ORDER: Fact Discovery completed by 11/22/2024. Status Report due by 11/29/2024. Joint Claim Construction Brief due by 8/29/2024. A Markman Hearing is set for 10/2/2024 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 7/24/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 7/28/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 3/15/24. (ntl) (Entered: 03/15/2024) (14) |
| Mar 11, 2024 | N/A | SO ORDERED, re 23 Stipulated Protective Order. Signed by Judge Gregory B. Williams on 3/11/24. (ntl) (Entered: 03/11/2024) (0) |
| Mar 7, 2024 | 23 | PROPOSED ORDER -- Proposed Stipulated Protective Order -- by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Tigan, Jeremy) (Entered: 03/07/2024) (30) |
| Mar 1, 2024 | N/A | SO ORDERED, re 22 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to March 7, 2024 filed by Biogen Swiss Manufacturing GmbH, Alkermes Pharma Ireland Limited, Biogen Inc. Signed by Judge Gregory B. Williams on 3/1/24. (ntl) (Entered: 03/01/2024) (0) |
| Feb 29, 2024 | 22 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to March 7, 2024 - filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Tigan, Jeremy) (Entered: 02/29/2024) (2) |
| Feb 22, 2024 | N/A | SO ORDERED, re 21 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to February 29, 2024 filed by Biogen Swiss Manufacturing GmbH, Alkermes Pharma Ireland Limited, Biogen Inc. Signed by Judge Gregory B. Williams on 2/22/24. (ntl) (Entered: 02/22/2024) (0) |
| Feb 21, 2024 | 21 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to February 29, 2024 - filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Tigan, Jeremy) (Entered: 02/21/2024) (2) |
| Feb 15, 2024 | 20 | NOTICE OF SERVICE of Plaintiffs Biogen Inc., Biogen Swiss Manufacturing GmbH, and Alkermes Pharma Ireland Limited's Initial Disclosures Identifying Accused Product and Asserted Patents filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH.(Tigan, Jeremy) (Entered: 02/15/2024) (3) |
| Feb 8, 2024 | 19 | NOTICE OF SERVICE of 1) Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Fed. R. Civ. P. 26(a)(1) Initial Disclosures; and 2) Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Stombaugh, Alexis) (Entered: 02/08/2024) (2) |
| Feb 8, 2024 | 18 | NOTICE OF SERVICE of (1) Plaintiffs Biogen Inc., Biogen Swiss Manufacturing GmbH, and Alkermes Pharma Ireland Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a); and (2) Plaintiffs Biogen Inc., Biogen Swiss Manufacturing GmbH, and Alkermes Pharma Ireland Limited's Initial Disclosures Pursuant to the District of Delaware Default Standard for Discovery filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH.(Tigan, Jeremy) (Entered: 02/08/2024) (3) |
| Feb 1, 2024 | 17 | PROPOSED ORDER -- Joint [Proposed] Scheduling Order -- re 15 Order,,,, by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Attachments: # 1 Cover Letter to The Honorable Gregory B. Williams)(Tigan, Jeremy) (Entered: 02/01/2024) (0) |
| Jan 22, 2024 | N/A | SO ORDERED, re 16 STIPULATION TO EXTEND TIME for the parties to file a joint proposed scheduling order pursuant to the Court's January 8, 2024 Oral Order (D.I. 15) to February 1, 2024 filed by Biogen Swiss Manufacturing GmbH, Alkermes Pharma Ireland Limited, Biogen Inc. Signed by Judge Gregory B. Williams on 1/22/24. (ntl) (Entered: 01/22/2024) (0) |
| Jan 19, 2024 | 16 | STIPULATION TO EXTEND TIME for the parties to file a joint proposed scheduling order pursuant to the Court's January 8, 2024 Oral Order (D.I. 15) to February 1, 2024 - filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Tigan, Jeremy) (Entered: 01/19/2024) (2) |
| Jan 8, 2024 | 15 | ORAL ORDER: IT IS HEREBY ORDERED that, not later than fourteen (14) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order that is consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling in the joint proposed Scheduling Order that the Court needs to address) or to schedule a scheduling conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those disputes or other issues appear and detail each party's position on those disputes or other issues. ORDERED by Judge Gregory B. Williams on 1/8/2024. (ntl) (Entered: 01/08/2024) (0) |
| Oct 12, 2023 | N/A | Pro Hac Vice Attorneys Michael J. Gaertner, Jacob C. Britz, Carolyn A. Blessing, Timothy F. Peterson for Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 10/12/2023) (0) |
| Oct 12, 2023 | N/A | SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing, Timothy F. Peterson, and Jacob Britz filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Gregory B. Williams on 10/12/23. (ntl) (Entered: 10/12/2023) (0) |
| Oct 11, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing, Timothy F. Peterson, and Jacob Britz - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Stombaugh, Alexis) (Entered: 10/11/2023) (7) |
| Oct 11, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 10/11/2023) (3) |
| Oct 11, 2023 | 12 | ANSWER to 1 Complaint, and Affirmative Defenses by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) (Entered: 10/11/2023) (20) |
| Jul 19, 2023 | N/A | Pro Hac Vice Attorney Adam L. Perlman, Takashi Okuda, Ernest Yakob and Arlene L. Chow for Alkermes Pharma Ireland Limited, Biogen Inc. and Biogen Swiss Manufacturing GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 07/19/2023) (0) |
| Jul 19, 2023 | N/A | SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Arlene L. Chow, Ernest Yakob, Takashi Okuda, and Adam L. Perlman filed by Biogen Swiss Manufacturing GmbH, Alkermes Pharma Ireland Limited, Biogen Inc. Signed by Judge Gregory B. Williams on 7/19/23. (ntl) (Entered: 07/19/2023) (0) |
| Jul 18, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Arlene L. Chow, Ernest Yakob, Takashi Okuda, and Adam L. Perlman - filed by Alkermes Pharma Ireland Limited, Biogen Inc., Biogen Swiss Manufacturing GmbH. (Tigan, Jeremy) (Entered: 07/18/2023) (6) |
| Jul 14, 2023 | 10 | WAIVER OF SERVICE returned executed by Biogen Swiss Manufacturing GmbH, Biogen Inc., Alkermes Pharma Ireland Limited: For Zydus Worldwide DMCC waiver sent on 7/13/2023, answer due 10/11/2023. (Tigan, Jeremy) (Entered: 07/14/2023) (1) |
| Jul 14, 2023 | 9 | WAIVER OF SERVICE returned executed by Biogen Swiss Manufacturing GmbH, Biogen Inc., Alkermes Pharma Ireland Limited: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 7/13/2023, answer due 10/11/2023. (Tigan, Jeremy) (Entered: 07/14/2023) (1) |
| Jul 14, 2023 | 8 | WAIVER OF SERVICE returned executed by Biogen Swiss Manufacturing GmbH, Biogen Inc., Alkermes Pharma Ireland Limited: For Zydus Lifesciences Limited waiver sent on 7/13/2023, answer due 10/11/2023. (Tigan, Jeremy) (Entered: 07/14/2023) (1) |
| Jul 12, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 07/12/2023) (0) |
| Jul 6, 2023 | 7 | Summons Issued as to Zydus Lifesciences Limited on 7/6/2023; Zydus Pharmaceuticals (USA) Inc. on 7/6/2023; Zydus Worldwide DMCC on 7/6/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mkr) (Entered: 07/06/2023) (0) |
| Jul 6, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc., Corporate Parent Biogen MA Inc., Corporate Parent Biogen Swiss Investments GmbH, Corporate Parent Biogen U.S. Corporation for Biogen Swiss Manufacturing GmbH filed by Biogen Inc., Biogen Swiss Manufacturing GmbH. (mkr) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alkermes plc for Alkermes Pharma Ireland Limited and BlackRock, Inc. Corporate Parent for Alkermes plcs filed by Alkermes Pharma Ireland Limited. (mkr) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,669,281 B1; 9,090,558 B2; 10,080,733 B2. (mkr) (Entered: 07/06/2023) (1) |
| Jul 6, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/26/2023 (Biogen); 5/29/2023 (Alkermes). Date of Expiration of Patent: 09/20/2033.Thirty Month Stay Deadline: 11/29/2025. (mkr) (Entered: 07/06/2023) (1) |
| Jul 6, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 07/06/2023) (3) |
| Jul 6, 2023 | 1 | Complaint* (1) |
